Company Revenue

The company's orthopedic sales grew below-market at 2% in 2024 as it worked through significant supply chain challenges....

The company's orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand....

The company's orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds....

The company grew in the high-teens in the third quarter of 2024, as its wide-ranging portfolio insulated it from market...

The company grew in the mid-single digits, driven by its broad product portfolio and increasing U.S. market penetration....

The company grew in the mid-single digits on a pro forma basis in the third quarter of 2024 as it...

The company grew 63% on a reported basis in the third quarter of 2024 as it anniversaried its merger with...

The company's orthopedic sales grew in the mid-single digits but headwinds in China will have an ongoing impact into 2025....

The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and...

The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash...